Rare diseases
Investigational molecules
Locations
Technologiepark, Hochbergerstrasse 60c, 4057
Kinarus AG focuses on COVID-19 research in SARS-CoV-2 infection, with attention to the course of illness in non-hospitalized patients and the progression of symptoms during recovery.
The sponsor’s activity is centered on clinical evaluation of treatments relevant to outpatient viral disease management and recovery outcomes.
Kinarus AG runs clinical trials in conditions such as COVID-19, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
